Association of serum paraoxonase enzyme activity and oxidative stress markers with dyslipidemia in obese adolescents

Indian Journal of Endocrinology and Metabolism

Volumn 18, Issue 3, 2014, Pages 340-344

  Zaki, Moushira ^a   El Bassyouni, Hala ^a   Kamal, Sanaa ^a   El Gammal, Mona ^a   Youness, Eman ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Dyslipidemia; obesity; oxidative stress; paraoxonase activity

Indexed keywords

EID: 84995751202     PISSN: 22308210     EISSN: 22309500     Source Type: Journal    
DOI: 10.4103/2230-8210.131173     Document Type: Article

References (34)

1. Kuno T, Hozumi M, Morinobu T, Murata T, Mingci Z, Tamai H. Antioxidant vitamin levels in plasma and low density lipoprotein of obese girls. Free Radic Res 1998;28:81-6.
2. Mutlu-Türkolu U, Oztezcan S, Telci A, Orhan Y, Aykaç-Toker G, Sivas A, et al. An increase in lipoprotein oxidation and endogenous lipidperoxides in serum of obese women. Clin Exp Med 2003;2:171-4.
3. Van Gaal LF, Zhang A, Steijaert MM, De Leeuw IH. Human obesity: From lipid abnormalities to lipid oxidation. Int J Obes Relat Metab Disord 1995;19:S21-6.
4. Myara I, Alamowitch C, Michel O, Heudes D, Bariety J, Guy-Grand B, et al. Lipoprotein oxidation and plasma vitamin E in nondiabetic normotensive obese patients. Obes Res 2003;11:112-20
5. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 1997;272:20963-6.
6. Laplaud PM, Dantoine T, Chapman MJ. Paraoxonase as a risk markerfor cardiovascular disease: Facts and hypotheses. Clin Chem Lab Med 1998;37:431-41.
7. Ng CJ, Shih DM, Hama SY, Villa N, Navab M, Reddy ST. The paraoxonasegene family and atherosclerosis. Free Radic Biol Med 2005;38:153-63.
8. Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR, Grandjean P. Plasma malondialdehyde as biomarker for oxidative stress: Reference interval and effects of life-style factors. Clin Chem 1997;43:1209-14.
9. De Souza CA, Van Guilder GP, Greiner JJ, Smith DT, Hoetzer GL, Stauffer BL. Basal endothelial nitric oxide release is preserved in overweight and obese adults. Obes Res 2005;13:1303-6.
10. Esposito K, Ciotola M, Schisano B, Misso L, Giannetti G, Ceriello A, et al. Oxidative stress in the Metabolic Syndrome. J Endocrinol Invest 2006;29:791-5.
11. Shimabukuro M, Ohneda M, Lee Y, Unger RH. Role of nitric oxide in obesity-induced β cell disease. J Clin Invest 1997;100:290-5.
12. Chakraborty K, Khan GA, Banerjee P, Ray U, Sinha AK. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin. Platelets 2003;14:421-7.
13. Egyptian growth curves. Egyptian growth curves. Diabetes Endocrine Metabolism Pediatric Unit Cairo University Childern's Hospital. Available from: http://dempuegypt.blogspot.com/[Last accessed on 2009 Aug 13].
14. Ruiz-Larrea MB, Leal AM, Liza M, Lacort M, de Groot H. Antioxidant effects of estradiol and 2-hydroxyestradiolon iron-induced lipid peroxidation of rat livermicrosomes. Steroids 1994;59:383-8.
15. Moshage H, Kok B, Huizenga JR, Jansen PL. Nitrite and nitrate determination in plasma: A critical evaluation. Clin Chem 1995;41:892-6.
16. Higashino K, Takahashi Y, Yamamura Y. Release of phenyl acetate esterase from liver microsomes by carbon tetrachloride. Clin Chim Acta 1972;41:313-20.
17. Watson AD, Berliner JA, Hama SY, La Du BN, Faull KF, Fogelman AM, et al. Protective effect of highdensity lipoprotein associated paraoxonase. Inhibition ofthe biological activity of minimally oxidized low density lipoprotein. J Clin Invest 1995;96:2882-91.
18. Lewis GF, Steiner G. Acute effect s of insulin in the control of VLDL production in humans. Implications for insulin-resistant state. Diabetes Care 1996;19:390-3.
19. Arner P. Differences in lipolysis between human subcutaneous and omental adipose tissues. Ann Med 1995;27:435-8.
20. Keaney JF Jr, Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, et al. Framingham Study. Obesity and systemic oxidative stress: Clinical correlates of oxidative stress inthe Framingham Study. Arterioscler Thromb Vasc Biol 2003;23:434-9.
21. Davì G, Guagnano MT, Ciabattoni G, Basili S, Falco A, Marinopiccoli M, et al. Platelet activation in obese women: Role of inflammation and oxidant stress. JAMA 2002;288:2008-14.
22. Rector RS, Warner SO, Liu Y, Hinton PS, Sun GY, Cox RH, et al. Exercise and diet induced weight loss improves measures of oxidative stress and insulin sensitivity in adults with characteristics of the metabolic syndrome. Am J Physiol Endocrinol Metab 2007;293:E500-6.
23. Aviram M, Rosenblat M, Billecke S, Erogul J, Sorenson R, Bisgaier CL, et al. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic Biol Med 1999;26:892-904.
24. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994;344:793-5.
25. Mackness MI, Harty D, Bhatnagar D, Winocour PH, Arrol S, Ishola M, et al. Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. Atherosclerosis 1991;86:193-9.
26. Sentí M, Tomás M, Fitó M, Weinbrenner T, Covas MI, Sala J, et al. Antioxidant paraoxonase 1 activity in the metabolic syndrome. J Clin Endocrinol Metab 2003;88:5422-6.
27. Van Gaal LF, Vertommen J, De Leeuw IH. The in vitro oxidizabilitiy of lipoprotein particals in obese and non-obese subjects. Atherosclerosis 1998;137 (suppl):S39-44.
28. Tack CJ, Smits P, Demacker PN, Stalenhoef AF. Troglitazone decreases the proportion of small dense LDL and increases the resistance of LDL to oxidation in obese subjects. Diabetes Care 1998;21:796-9.
29. Prazny M, Skrha J, Hilgertova J. Plasma Malondialdehyde and Obesity: Is There A Relationship? Clin Chem Lab Med 1999;37:1129-30.
30. Halliwell B, Gutteridge JMC, Cross CE. Free Radicals, Antioxidants, and Human Disease: Where Are We Now? J Lab Clin Med 1992;119:598-620.
31. Maniscalco M, de Laurentiis G, Zedda A, Faraone S, Giardiello C, Cristiano S, et al. Exhaled nitric oxide in severe obesity: Effect of weight loss. Respir Physiol Neurobiol 2007;156:370-3.
32. Mather KJ, Lteif A, Steinberg HO, Baron AD. Interactions between endothelin and nitric oxide in the regulation of vascular tone inobesity and diabetes. Diabetes 2004;53:2060-6.
33. Gruber HJ, Mayer C, Mangge H, Fauler G, Grandits N, Wilders-Truschnig M. Obesity reduces the bioavailability of nitric oxide in juveniles. Int J Obes (Lond) 2008;32:826-31.
34. Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol 1999;83:25F-9.